Form 4: CoreWeave CDO Sells $3.4M in Stock via 10b5-1 Plan

CoreWeave's Chief Development Officer, Brannin McBee, reported the sale of 33,335 Class A Common Stock shares through pre-arranged trading plans.

Summary

• Brannin McBee, Chief Development Officer of CoreWeave, Inc., reported transactions involving Class A and Class B Common Stock.
• All transactions occurred on January 26, 2026, and were executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.
• A total of 33,335 shares of Class A Common Stock were sold from two Grantor Retained Annuity Trusts (GRATs).
• The sales were preceded by the conversion of an equal number of Class B Common Stock shares into Class A Common Stock.
• Sales from the Canis Major 2025 GRAT totaled 25,000 Class A shares at weighted average prices ranging from $98.18 to $108.54.
• Sales from the Canis Minor 2025 GRAT (where the reporting person's spouse is beneficiary and trustee) totaled 8,335 Class A shares at weighted average prices ranging from $98.18 to $108.54.
• Following these transactions, the Canis Major 2025 GRAT holds 5,775,000 Class B shares, and the Canis Minor 2025 GRAT holds 924,985 Class B shares.
• Additional indirect beneficial ownership includes 1,800 Class A shares held by the reporting person's child and 2,280,300 Class B shares held by the spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can be seen negatively, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic selling based on undisclosed information. It's a routine liquidity event for an executive.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment rather than a reaction to new, undisclosed negative information.

Negatives

• A significant number of shares (33,335 Class A Common Stock) were sold by a key executive, which could be perceived as a reduction in insider confidence, despite the 10b5-1 plan.

Future Outlook

NA

Industry Context

This is an individual insider transaction and does not directly relate to broader industry trends or competitors, other than reflecting the liquidity options available to executives in publicly traded companies.

Related Party Transactions

• The reported securities are held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.
• The reported securities are held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.
• Indirect beneficial ownership includes shares held by the reporting person's child and spouse.

Stakeholder Impact

• Shareholders may interpret the insider selling as a slight negative signal, though the 10b5-1 plan mitigates this concern.
• The transactions provide liquidity for the executive, which is a common practice for long-term compensation plans.

Key Dates

Recommendation

The reported transactions are routine insider sales executed under a pre-arranged 10b5-1 trading plan. This type of transaction typically does not signal a change in the company's fundamental outlook or warrant a change in investment recommendation. Investors should focus on the company's operational performance and broader market conditions rather than this specific insider transaction.

Keywords

CoreWeave, CRWV, Form 4, Insider Trading, Stock Sale, Brannin McBee, Chief Development Officer, 10b5-1 Plan, Class A Common Stock, Class B Common Stock, Grantor Retained Annuity Trust, GRAT